SAB Biotherapeutics

SABS

NASDAQHealth Care

Income Statement

Total Revenue$1.32M

Gross Profit$1.32M

Operating Income$-42.91M

EBITDA$-28.99M

EBIT$-33.79M

Pre-tax Income$18.74M

Net Income$-34.11M

Cash Equivalent$12.34M

Total Debt$5M

Book Value$40.45M

Book Value Per Share4.38

Return on Equity (ROE)-131.33%

Return on Assets (ROA)-77.17%

Return on Invested Capital (ROI)-114.97%

Net Profit Margin-2579.03%

Current Ratio2.98

Quick Ratio2.61

Long-Term Debt / Equity0.00